Provention reports positive data from Phase Ib trial of lupus drug
Lupus is a chronic autoimmune disorder characterised by an abnormal over activation of B cells. Credit: Nephron.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more